Search

Search Results

• Treatment Efficacy for Pediatric Acute Myeloid Leukemias: Results of a Single-Center Trial

  E.V. Inyushkina, Sergei Olegovich Gunyakov, A.V. Bogucharskii, V.O. Stepanova

  142-151

  01.04.2026

• Primary Central Nervous System Lymphoma: A Literature Review, Diagnosis, Treatment, and Prognosis

  Selmi Faikovna Ramazanova, A.V. Arakelyan, A.A. Semenova, O.Yu. Baranova, D.N. Tupitsyna, M.Yu. Kichigina, O.P. Trofimova, G.D. Petrova, A.S. Subbotin, V.O. Shpirko, U.G. Koshkina, N.O. Zemlyakov, K.R. Gadzhibekov, G.S. Tumyan

  191-203

  01.04.2026

• Characteristic Features of COVID-19 and Opportunities for Its Prevention in Multiple Myeloma Patients

  Darya Aleksandrovna Chebykina, I.I. Krobinets

  96-103

  01.01.2026

• The Prognostic Value of Positron Emission Tomography Findings in the Treatment of Primary Mediastinal (Thymic) Large B-Cell Lymphoma

  A.S. Subbotin, Arman Vachakanovich Arakelyan, G.S. Tumyan, V.V. Solomyanyi, B.M. Khakulova, A.A. Semenova, M.Yu. Kichigina, I.Z. Zavodnova, V.O. Shpirko, Yu.I. Klyuchagina, S.F. Ramazanova, U.G. Koshkina, O.P. Trofimova, M.A. Senchenko, V.Yu. Kirsanov

  326-339

  01.10.2025

• DNA Methylation Genes in Multiple Myeloma: What We Already Know and How It Can Be Used?

  Daria Aleksandrovna Chebykina, E.V. Motyko, A.N. Kirienko, D.V. Kustova, O.B. Krysiuk, S.V. Sidorkevich, I.S. Martynkevich

  315-325

  01.10.2025

• The Prognostic Value of Minimal Residual Disease Assessed During the Remission Induction Stage in Acute Myeloid Leukemia Patients

  Irina Vladimirovna Galtseva, E.N. Parovichnikova, Yu.O. Davydova, N.M. Kapranov, K.A. Nikiforova, Yu.A. Chabaeva, L.A. Kuzmina, I.A. Lukianova, V.V. Troitskaya, T.V. Gaponova, S.M. Kulikov

  233-241

  01.07.2025

• Current Strategy and Principles of Multiple Myeloma Treatment: A Literature Review

  Aleksander Sergeevich Luchinin, A.A. Semenova, S.V. Semochkin

  153-162

  01.04.2025

• Options for Program Chemotherapy and Their Outcomes in Patients with Newly Diagnosed Mantle Cell Lymphoma Based on the Data from a Single Center

  Ulyana Gordeevna Koshkina, G.S. Tumyan, A.A. Semenova, M.Yu. Kichigina, I.Z. Zavodnova, D.N. Tupitsyna, E.V. Paramonova, A.S. Antipova, V.O. Shpirko, Yu.I. Klyuchagina, S.F. Ramazanova, A.V. Arakelyan, G.D. Petrova, O.Yu. Baranova, N.A. Kupryshina, E.A. Osmanov

  121-133

  01.04.2025

• Functional Cure as a New Concept of Therapy for Multiple Myeloma

  Sergei Vyacheslavovich Semochkin

  105-120

  01.04.2025

• Esophagogastric Bleedings in Patients with Ph-Negative Myeloproliferative Neoplasms and Extrahepatic Portal Hypertension

  Pavel Artemovich Batrov, K.I. Danishian, E.P. Sysoeva, K.R. Sabirov, O.M. Averbukh, O.A. Soboleva, E.A. Kitsenko, E.A. Lukina

  163-170

  01.04.2025

• Treatment of Patients with Relapsed/Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Own Data and Literature Review

  Arman Vachakanovich Arakelyan, G.S. Tumyan, A.A. Semenova, M.Yu. Kichigina, I.Z. Zavodnova, D.N. Tupitsyna, E.V. Paramonova, A.S. Antipova, V.O. Shpirko, Yu.I. Klyuchagina, S.F. Ramazanova, U.G. Koshkina, I.S. Monin, N.M. Zolotaikina, G.D. Petrova, O.P. Trofimova, A.S. Subbotin, M.A. Senchenko, V.Yu. Kirsanov

  38-50

  01.01.2025

• Long-Term Outcomes of Immunosuppressive Therapy for Aplastic Anemia: A Single-Center Experience

  Elena Romanovna Shilova, N.A. Romanenko, D.A. Chebykina, T.V. Glazanova, M.N. Zenina, I.E. Pavlova, S.S. Bessmeltsev

  321-330

  09.06.2023

• Long-Term Results of Classical Hodgkin’s Lymphoma Treatment in Real-World Clinical Practice: Experience of Novosibirsk Hematological Unit

  Mariya Sergeevna Voitko, T.I. Pospelova, I.N. Nechunaeva, Ya.Yu. Shebunyaeva

  192-199

  03.03.2023

• Ibrutinib Efficacy in First-Line Therapy of High-Risk Patients Vs. Second- and Third-Line Therapies of Resistant Chronic Lymphocytic Leukemia

  Nadezhda Viktorovna Kurkina, E.A. Repina, P.V. Volkova, A.A. Repin

  209-212

  03.03.2023

• Efficacy Predictors of the Third-Line Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Phase of Chronic Myeloid Leukemia: Results of a Multi-Center Study

  E.G. Lomaia, V.A. Shuvaev, Tamara Vangelevna Chitanava, Yu.D. Matvienko, I.S. Martynkevich, S.V. Voloshin, E.V. Efremova, E.S. Mileeva, M.S. Fominykh, A.E. Kersilova, E.V. Karyagina, N.V. Il’ina, N.V. Dorofeeva, N.V. Medvedeva, A.V. Klimovich, T.V. Shneider, S.A. Stepanova, N.F. Polezhaikovskaya, N.T. Siordiya, E.I. Sbityakova, N.S. Lazorko, E.N. Tochenaya, D.V. Motorin, N.A. Shnalieva, Yu.A. Alekseeva, D.B. Zammoeva, A.Yu. Zaritskey

  271-281

  01.07.2022

• Protocol ALL-IC BFM 2002: Outcomes of Pediatric Acute Lymphoblastic Leukemia Treatment under Multi-Center Clinical Trial

  Timur Teimurazovich Valiev, M.A. Shervashidze, I.V. Osipova, T.I. Burlutskaya, N.A. Popova, N.S. Osmulskaya, G.A. Aleskerova, S.L. Sabantsev, Z.S. Gordeeva, V.Yu. Smirnov, O.A. Poberezhnaya, S.N. Yuldasheva, I.A. Babich, N.A. Batmanova, S.R. Varfolomeeva

  119-129

  01.04.2022

• A Rationale for a New Operational Integrated Quality and Efficiency Index for Assessing the Performance of Hematological Services in Constituent Entities of the Russian Federation

  Elena Nikolaevna Parovichnikova, T.Ts. Garmaeva, O.V. Lazareva, K.A. Lukina, Yu.A. Chabaeva, S.M. Kulikov, V.V. Troitskaya, T.V. Gaponova, L.I. Menshikova, V.G. Savchenko

  1-15

  01.01.2022

• Current Issues of Targeted Therapy of Polycythemia Vera

  Anait Levonovna Melikyan, I.N. Subortseva

  355-360

  01.07.2021

• Opportunities of Chronic Myeloid Leukemia Treatment with Reduced Doses of Tyrosine Kinase Inhibitors

  Margarita Anatolevna Guryanova, E.Yu. Chelysheva, A.G. Turkina

  118-128

  01.01.2021

• Early Response and Long-Term Outcomes of Ruxolitinib Therapy in Myelofibrosis: Multicenter Retrospective Study in 10 Centers of the Russian Federation

  E.G. Lomaia, Nadiya Tamazovna Siordiya, O.M. Senderova, O.E. Ochirova, E.B. Zhalsanova, A.Yu. Furtovskaya, G.P. Dimov, M. G. Pozina, O.Yu. Li, K.B. Trizna, M.A. Mikhalev, E.V. Sokurova, A.A. Otmorskaya, A.S. Khazieva, V.V. Ust’yantseva, Yu.D. Rogovaya, A.Yu. Zaritskey

  335-345

  01.07.2020

• Long-Term Outcomes of Nivolumab Therapy in Patients with Relapsed/Refractory Classic Hodgkin’s Lymphoma after High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Real Clinical Practice

  Kirill Viktorovich Lepik, N.P. Volkov, N.B. Mikhailova, E.V. Kondakova, L.A. Tsvetkova, Yu.R. Zalyalov, E.E. Lepik, L.V. Fedorova, A.V. Beinarovich, M.V. Demchenkova, O.G. Smykova, P.V. Kotselyabina, I.S. Moiseev, V.V. Baikov, B.V. Afanasyev

  280-288

  01.07.2020

• Diagnosis and Treatment of Clonal Myeloproliferative Neoplasms with Eosinophilia

  Irina Semenovna Nemchenko, N.N. Tsyba, A.G. Turkina, E.Yu. Chelysheva, O.A. Shukhov, A.M. Kovrigina, T.N. Obukhova

  161-169

  01.04.2020

• Infectious Complications after Haploidentical Hematopoietic Stem Cells Transplantation in Patients with High-Risk Tumors of Hematopoietic and Lymphoid Tissues: A Single-Center Experience

  Yurii Sergeevich Osipov, S.S. Bessmeltsev, G.N. Salogub, V.V. Ivanov, E.S. Mikhailov, N.A. Zhukova, A.V. Chechetkin

  406-415

  01.10.2019

• Primary Bone Lymphomas: Long-Term Results of a Prospective Single-Center Trial

  Anna Konstantinovna Smol’yaninova, N.G. Gabeeva, V.E. Mamonov, S.A. Tatarnikova, L.G. Gorenkova, D.S. Badmadzhapova, A.M. Kovrigina, E.G. Gemdzhian, E.E. Zvonkov

  247-262

  01.07.2019

• Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia: Challenges, Characteristics, and Analysis of Clinical Experience

  Elena Romanovna Shilova, T.V. Glazanova, Zh.V. Chubukina, O.E. Rozanova, M.N. Zenina, A.V. Seltser, V.I. Rugal, V.A. Balashova, V.A. Kobilyanskaya, I.I. Krobinets, V.Yu. Udal’eva, I.I. Zotova, L.V. Stelmashenko, N.A. Romanenko, T.B. Zamotina, I.V. Khorsheva, S.V. Voloshin

  319-328

  01.07.2019

• Management of Chronic Myeloid Leukemia Patients During Pregnancy (Analysis of Literature and Practical Recommendations)

  Ekaterina Yur’evna Chelysheva, A.G. Turkina, E.S. Polushkina, M.A. Vinogradova, R.G. Shmakov

  202-210

  01.04.2019

• PD-1 Blockade with Nivolumab as a New Immunotherapy for Classical Hodgkin’s Lymphoma

  Elena Andreevna Demina

  213-219

  01.07.2018

• Outcome of Classical Hodgkin’s Lymphoma Treatment Based on High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation: The Experience in the NI Pirogov Russian National Medical Center of Surgery

  Nikita Evgen’evich Mochkin, V.O. Sarzhevskii, Yu.N. Dubinina, E.G. Smirnova, D.A. Fedorenko, A.E. Bannikova, D.S. Kolesnikova, V.S. Bogatyrev, N.M. Faddeev, V.Ya. Mel’nichenko

  234-240

  01.07.2018

• Tyrosine Kinase Inhibitor Resistance in Patients with Chronic Myeloid Leukemia: A 10-Year Study of BCR-ABL Gene Mutation Profile in Russia (2006–2016)

  Vera Vyacheslavovna Tikhonova, M.A. Isakov, V.A. Misyurin, Yu.P. Finashutina, L.A. Kesaeva, N.A. Lyzhko, I.N. Soldatova, N.N. Kasatkina, E.N. Misyurina, A.V. Misyurin

  227-233

  01.07.2018

• Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of New Drugs

  Ol’ga Vladislavovna Pirogova, E.I. Darskaya, V.V. Porunova, O.V. Kudyasheva, A.G. Smirnova, I.S. Moiseev, E.V. Babenko, B.V. Afanas’ev

  187-191

  01.04.2018

• Pharmacoeconomic Analysis of the Use of Thrombopoietin Receptors Agonists in Idiopathic Thrombocytopenic Purpura Therapy

  Vasilii Anatol’evich Shuvaev, S.V. Voloshin, A.K. Hadzhidis, A.V. Chechetkin

  435-442

  01.10.2017

• Prognostic Value and Correlation Between WT1 Overexpression and NPM1 Mutation in Patients with Acute Myeloblastic Leukemia

  L.L. Girshova, Irina Garmaevna Budaeva, E.G. Ovsyannikova, S.O. Kuzin, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, K.V. Bogdanov, O.S. Pisotskaya, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskii

  485-493

  01.10.2017

• Treatment of Drug-Resistant Mycosis Fungoides and Sezary Syndrome

  Liliya Gamilevna Gorenkova, E.A. Penskaya, S.K. Kravchenko, A.M. Kovrigina, T.N. Moiseeva, A.I. Vorob’ev

  366-371

  01.07.2017

• Bortezomib Combination Therapy of Relapsed and Refractory Acute Lymphoblastic Leukemia in Children

  Natal’ya Andreevna Batmanova, M.A. Shervashidze, A.V. Popa, L.Yu. Grivtsova, I.N. Serebryakova, G.L. Mentkevich

  381-389

  01.07.2017

• Brentuximab Vedotin: New Possibilities for Treatment of Relapses and Refractory Hodgkin’s Lymphomas

  Elena Andreevna Demina

  398-405

  01.10.2016

• Molecular Monitoring of RUNX1-RUNX1T1 Transcript Level in Acute Myeloblastic Leukemias on Treatment

  L.L. Girshova, Ekaterina Gennad’evna Ovsyannikova, S.O. Kuzin, E.N. Goryunova, R.I. Vabishchevich, A.V. Petrov, D.V. Motorin, D.V. Babenetskaya, V.V. Ivanov, K.V. Bogdanov, I.V. Kholopova, T.S. Nikulina, Yu.V. Mirolyubova, Yu.A. Alekseeva, A.Yu. Zaritskii

  456-464

  01.10.2016

• Chronic Myeloid Leukemia: Long-Term Experience of Target Therapy

  K.M. Abdulkadyrov, Vasilii Anatol’evich Shuvaev, I.S. Martynkevich, M.S. Fominykh, N.A. Potikhonova, I.I. Zotova, V.Yu. Udal’eva, R.A. Golovchenko, N.V. Shakhvorostova, D.I. Shikhbabaeva, M.N. Zenina, S.A. Tiranova, S.A. Kudryashova, L.S. Martynenko, M.P. Ivanova, N.Yu. Tsybakova, E.V. Petrova, L.B. Polushkina, E.V. Kleina

  54-60

  01.01.2016

• Acute Myeloid Leukemias: 10-Year Therapy Experience

  Ol’ga Yur’evna Baranova, A.S. Antipova, O.D. Zakharov, N.A. Falaleeva, G.I. Kaletin, A.D. Shirin, G.R. Arakelyan, N.N. Tupitsyn, M.A. Frenkel’, N.A. Kupryshina, T.N. Obukhova, E.V. Domracheva, V.B. Larionova, E.V. Ogorodnikova, E.A. Osmanov

  287-301

  01.07.2015

• High-Dose Chemotherapy and Autologous Stem Cells Transplantation for Relapsed/Refractory Hodgkin’s Lymphoma. Is There an Equal Right to Life?

  N.V. Zhukov, A.G. Rumyantsev, A.L. Uss, N.F. Milanovich, V.V. Ptushkin, B.V. Afanasyev, N.B. Mikhaylova, V.B. Larionova, E.A. Demina, E.E. Karamanesht, N.G. Tyurina, M.A. Vernyuk, A.D. Kaprin

  317-326

  01.07.2014

• Association between HLA-DRB1 alleles and response to imatinib in chronic myeloid leukemia

  E.G. Ovsyannikova, I.L. Davydkin, E.A. Popov, L.V. Zaklyakova, B.N. Levitan

  312-317

  01.07.2013